Pancreatic Cancer Research

ResearcherJikei University School of MedicineNo recent work listed

Nobuhiro Saito

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6795-4093; OpenAlex author ID A5042955332. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper

Papers 6

  1. Suppression of lysosomal acid alpha-glucosidase impacts the modulation of transcription factor EB translocation in pancreatic cancer. Co-author DOI 10.1111/cas.14921↗
  2. Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB. First author DOI 10.18632/oncotarget.24577↗
  3. Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo. Co-author DOI 10.18632/oncotarget.24608↗
  4. Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-κB activation. Co-author DOI 10.1016/j.surg.2016.12.008↗
  5. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection. Co-author DOI 10.21873/anticanres.11378↗
  6. New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer. Co-author DOI 10.1016/j.jss.2016.06.047↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshihiro Shirai · 6 shared papers, 2016–2021 · strength 0.49
  2. Takashi Horiuchi · 6 shared papers, 2016–2021 · strength 0.49
  3. Katsuhiko K. Yanaga · 6 shared papers, 2016–2021 · strength 0.49
  4. Hiroaki Shiba · 5 shared papers, 2016–2018 · strength 0.36
  5. Tadashi Uwagawa · 5 shared papers, 2016–2018 · strength 0.36
  6. Koichiro Haruki · 4 shared papers, 2016–2018 · strength 0.29
  7. Toru Ikegami · 1 shared paper, 2021 · strength 0.12
  8. Tomohiko Taniai · 1 shared paper, 2021 · strength 0.12
  9. Ryoga Hamura · 1 shared paper, 2021 · strength 0.12
  10. Hiroshi Sugano · 1 shared paper, 2018 · strength 0.08
  11. Kenei Furukawa · 1 shared paper, 2017 · strength 0.07
  12. Taro Sakamoto · 1 shared paper, 2017 · strength 0.07
  13. Yuki Fujiwara · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.